Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

10x Genomics (TXG) Depreciation & Amortization (CF) (2018 - 2025)

10x Genomics (TXG) has disclosed Depreciation & Amortization (CF) for 8 consecutive years, with $10.1 million as the latest value for Q4 2025.

  • Quarterly Depreciation & Amortization (CF) rose 15.03% to $10.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $36.2 million through Dec 2025, up 0.89% year-over-year, with the annual reading at $36.2 million for FY2025, 0.89% up from the prior year.
  • Depreciation & Amortization (CF) hit $10.1 million in Q4 2025 for 10x Genomics, down from $10.3 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $10.3 million in Q3 2025 to a low of $4.8 million in Q1 2021.
  • Historically, Depreciation & Amortization (CF) has averaged $7.7 million across 5 years, with a median of $7.9 million in 2025.
  • Biggest five-year swings in Depreciation & Amortization (CF): surged 58.57% in 2021 and later dropped 12.89% in 2025.
  • Year by year, Depreciation & Amortization (CF) stood at $5.8 million in 2021, then grew by 12.8% to $6.5 million in 2022, then soared by 49.01% to $9.7 million in 2023, then dropped by 9.95% to $8.8 million in 2024, then rose by 15.03% to $10.1 million in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for TXG at $10.1 million in Q4 2025, $10.3 million in Q3 2025, and $7.8 million in Q2 2025.